NYSEAMERICAN:SENSSenseonics Stock Price, Forecast & News

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 2 sell ratings, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Senseonics.

Senseonics is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020.
View our earnings forecast for Senseonics.

Senseonics will be holding an earnings conference call on Monday, August 10th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Senseonics Holdings Inc (NYSEAMERICAN:SENS) issued its quarterly earnings results on Tuesday, June, 9th. The company reported ($0.21) earnings per share for the quarter, missing the consensus estimate of ($0.12) by $0.09. The firm had revenue of $0.03 million for the quarter, compared to the consensus estimate of $0.77 million.
View Senseonics' earnings history.

8 equities research analysts have issued 12 month price targets for Senseonics' shares. Their forecasts range from $0.25 to $2.00. On average, they anticipate Senseonics' share price to reach $1.06 in the next year. This suggests a possible upside of 134.9% from the stock's current price.
View analysts' price targets for Senseonics.

Media coverage about SENS stock has been trending somewhat negative recently, InfoTrie reports. The research group rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Senseonics earned a media sentiment score of -1.4 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term.
View the latest news about Senseonics.

Senseonics saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 25,150,000 shares, an increase of 5.1% from the June 15th total of 23,940,000 shares. Based on an average daily trading volume, of 3,040,000 shares, the short-interest ratio is presently 8.3 days. Currently, 16.5% of the company's stock are sold short.
View Senseonics' Current Options Chain.

Some companies that are related to Senseonics include Profound Medical (PRN), Volpara Health Tech (VHT), MaxCyte (MXCT), Exagen (XGN), Akumin (AKU), Palatin Technologies (PTN), Yourgene Health (YGEN), Oncimmune (ONC), Lexagene (LXG), Oncosil Medical (OSL), SQI Diagnostics (SQD), Genedrive (GDR), BARD1 Life Sciences (BD1), Sernova (SVA) and GeneNews (GEN).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Senseonics investors own include Advanced Micro Devices (AMD), Agile Therapeutics (AGRX), Amarin (AMRN), Crispr Therapeutics (CRSP), Sorrento Therapeutics (SRNE), Tandem Diabetes Care (TNDM), VirnetX (VHC), Micron Technology (MU), Nabriva Therapeutics (NBRV) and Protalix Biotherapeutics (PLX).

Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS."

Senseonics' stock is owned by a variety of institutional and retail investors. Top institutional investors include NEA Management Company LLC (7.04%) and Magnolia Capital Advisors LLC (0.03%).
View institutional ownership trends for Senseonics.

SENS stock was sold by a variety of institutional investors in the last quarter, including NEA Management Company LLC.
View insider buying and selling activity for Senseonics.

SENS stock was bought by a variety of institutional investors in the last quarter, including Magnolia Capital Advisors LLC.
View insider buying and selling activity for Senseonics.

Shares of SENS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SENS stock can currently be purchased for approximately $0.45.

Senseonics has a market capitalization of $102.44 million. Senseonics employs 191 workers across the globe.

The official website for Senseonics is www.senseonics.com.

Senseonics' mailing address is 20451 Seneca Meadows Pkwy, GERMANTOWN, MD 20876-7005, United States. The company can be reached via phone at +1-301-5157260.